101. Mechanosensitive TREK-1 two-pore-domain potassium (K 2P ) channels in the cardiovascular system.
- Author
-
Wiedmann F, Rinné S, Donner B, Decher N, Katus HA, and Schmidt C
- Subjects
- Animals, Anti-Arrhythmia Agents pharmacology, Arrhythmias, Cardiac metabolism, Biomechanical Phenomena physiology, Cardiomegaly metabolism, Drug Development, Heart Failure metabolism, Humans, Lipid Bilayers metabolism, Potassium Channels, Tandem Pore Domain genetics, Xenopus laevis, Anti-Arrhythmia Agents metabolism, Cardiovascular System metabolism, Myocytes, Cardiac metabolism, Potassium metabolism, Potassium Channels, Tandem Pore Domain metabolism
- Abstract
TWIK-related K
+ channel (TREK-1) two-pore-domain potassium (K2P ) channels mediate background potassium currents and regulate cellular excitability in many different types of cells. Their functional activity is controlled by a broad variety of different physiological stimuli, such as temperature, extracellular or intracellular pH, lipids and mechanical stress. By linking cellular excitability to mechanical stress, TREK-1 currents might be important to mediate parts of the mechanoelectrical feedback described in the heart. Furthermore, TREK-1 currents might contribute to the dysregulation of excitability in the heart in pathophysiological situations, such as those caused by abnormal stretch or ischaemia-associated cell swelling, thereby contributing to arrhythmogenesis. In this review, we focus on the functional role of TREK-1 in the heart and its putative contribution to cardiac mechanoelectrical coupling. Its cardiac expression among different species is discussed, alongside with functional evidence for TREK-1 currents in cardiomyocytes. In addition, evidence for the involvement of TREK-1 currents in different cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia, is summarized. Furthermore, the role of TREK-1 and its interaction partners in the regulation of the cardiac heart rate is reviewed. Finally, we focus on the significance of TREK-1 in the development of cardiac hypertrophy, cardiac fibrosis and heart failure., Competing Interests: Declaration of competing interest The authors declare that they have no competing financial interests or personal relationships that could be perceived to have influenced the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF